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Abstract
DNA methylation is an important epigenetic mechanism that has been linked to complex disease
and is of great interest to researchers as a potential link between genome, environment, and
disease. As the scale of DNA methylation association studies approaches that of genome-wide
association studies (GWAS), issues such as population stratification will need to be addressed. It
is well-documented that failure to adjust for population stratification can lead to false positives in
genetic association studies, but population stratification is often unaccounted for in DNA
methylation studies. Here, we propose several approaches to correct for population stratification
using principal components from different subsets of genome-wide methylation data. We first
illustrate the potential for confounding due to population stratification by demonstrating
widespread associations between DNA methylation and race in 388 individuals (365 African
American and 23 Caucasian). We subsequently evaluate the performance of our principal-
components approaches and other methods in adjusting for confounding due to population
stratification. Our simulations show that 1) all of the methods considered are effective at removing
inflation due to population stratification, and 2) maximum power can be obtained with SNP-based
principal components, followed by methylation-based principal components, which out-perform
both surrogate variable analysis and genomic control. Among our different approaches to
computing methylation-based principal components, we find that principal components based on
CpG sites chosen for their potential to proxy nearby SNPs can provide a powerful and
computationally efficient approach to adjustment for population stratification in DNA methylation
studies when genome-wide SNP data are unavailable.
Introduction
DNA methylation is an epigenetic mechanism that typically involves the addition of a
methyl group to a cytosine base pair followed by a guanine (cytosine-phosphate-guanine, or
CpG site). Advances in technology and rapidly decreasing costs of data generation have led
to an increased focus on large-scale studies of DNA methylation in human subjects.
Through these studies, altered DNA methylation has been linked to diseases such as cancer,
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autism, and lupus in addition to environmental stressors such as smoking and age [Alisch, et
al. 2012; Breitling, et al. 2011; Christensen, et al. 2009; Cicek, et al. 2013; Coit, et al. 2013;
Numata, et al. 2012; Rakyan, et al. 2010; Selamat, et al. 2012; Sun, et al. 2013;
Teschendorff, et al. 2010; Wong, et al. 2013].
Recently, several DNA methylation studies have identified CpG sites where methylation
levels differed by race or ethnicity [Adkins, et al. 2011; Heyn, et al. 2013; Kwabi-Addo, et
al. 2010; Liu, et al. 2010; Nielsen, et al. 2010; Terry, et al. 2008]. These differences could
arise from epigenetic inheritance [Pembrey, et al. 2006; Richards 2008] or population-
specific environmental factors, but most are likely due to the presence of 1) between-
population differences in single nucleotide polymorphism (SNP) allele frequencies [Cavalli-
Sforza and Edwards 1967; Cavalli-Sforza, et al. 1994; Price, et al. 2006; The International
HapMap 3 Consortium, et al. 2010] and 2) allele-specific DNA methylation or methylation
quantitative trait loci (mQTLs) [Bell, et al. 2011; Boks, et al. 2009; Heijmans, et al. 2007;
Kerkel, et al. 2008; Schalkwyk, et al. 2010; Zhang, et al. 2010]. Regardless of the
mechanisms behind the observed differences in DNA methylation across populations, there
are no established methods to account for population stratification in methylation studies.
Population stratification is a well-known confounder in genome-wide association studies
(GWAS) [Cavalli-Sforza and Edwards 1967; Cavalli-Sforza, et al. 1994; Price, et al. 2006;
The International HapMap 3 Consortium, et al. 2010], and is likely to present a similar
problem in DNA methylation studies. Methods to account for population stratification in
GWAS include the use of genomic control to correct inflated test statistics [Bacanu, et al.
2000; Devlin and Roeder 1999; Devlin, et al. 2001a] and inclusion of the top principal
components (PCs) of genome-wide genotype data as covariates in association tests to serve
as proxies for individual ancestry [Price, et al. 2006]. These methods may be extended to
address population stratification in DNA methylation studies, though the lack of available
GWAS data presents a complication in many studies. PCs computed from methylation data
present one possible solution to this problem, though the efficacy of these approaches has
not been explored. In particular, the use of methylation-based PCs may present additional
complications, since in contrast with genetic variation, genomic patterns of DNA
methylation are known to vary with many factors beyond ancestry, including technical
factors, age [Alisch, et al. 2012; Christensen, et al. 2009; Numata, et al. 2012; Rakyan, et al.
2010; Teschendorff, et al. 2010], and cellular composition [Houseman, et al. 2012; Reinius,
et al. 2012]. In this manuscript, we develop several methylation-based principal component
approaches and assess their ability to account for population stratification in DNA
methylation studies when GWAS data may not be available.
Methods
For this study, we sought to 1) assess the potential for confounding due to population
stratification in DNA methylation analyses, and 2) compare the ability of different
approaches to account for population stratification. We first examined the potential for
confounding in a typical methylation dataset by testing >469K autosomal CpG sites for
association with self-reported race among 388 individuals self-identifying as African-
American or Caucasian. We next assessed the ability of approaches based on PCs from
genomic methylation or SNP data to adjust for population stratification based on the
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reduction in the number of CpG sites significantly associated with race after these PCs were
included as covariates in the analysis. For each approach we then performed simulations to
obtain estimates of type I error and power with or without population stratification. Finally,
we examined our ability to replicate published results in our data using each of these
approaches to adjust for population stratification.
Data
The data used in this study were collected as part of a larger study investigating the roles of
genetic and environmental factors in predicting response to stressful life events [Gillespie, et
al. 2009]. Individuals were recruited from the waiting rooms of a public hospital in Atlanta,
GA, and those providing informed consent participated in a verbal interview and provided
salivary and/or blood samples. All procedures in this study were approved by the
Institutional Review Boards of Emory University School of Medicine and Grady Memorial
Hospital.
To assess DNA methylation, we extracted DNA from whole blood at the Max Planck
Institute in Munich using the Gentra Puregene Kit (Qiagen). Genomic DNA was then
bisulfite converted using the Zymo EZ-96 DNA Methylation Kit (Zymo Research). We
assessed DNA methylation for 393 individuals at >480,000 CpG sites using Illumina
HumanMethylation450 BeadChip arrays, with hybridization and processing performed
according to the instructions of the manufacturer. For each CpG site and individual, we
collected two data points: M (the total methylated signal), and U (the total unmethylated
signal). We set to missing data points with 1) a detection p-value greater than 0.001 or 2) a
combined signal less than 25% of the total median signal and less than both the median
unmethylated and median methylated signal. We removed individual samples from analysis
if they had 1) a mean total signal less than half of the median of the overall mean signal or
2000 arbitrary units, or 2) a missingness rate above 5%. Similarly, we removed from
analysis CpG sites with a missingness rate above 10%. We then quantile-normalized the
signal data to remove systematic differences across individuals in overall signal distribution
(Supplementary Methods). Using the normalized signals, we then computed β-values for
each individual at each CpG site as the total methylated signal divided by the total signal:
For genotyping, we extracted DNA either from saliva (Oragene DNA, DNA Genotek,
Kanata, Ontario, Canada) or whole blood at Emory University. We used Illumina Omni-
Quad 1M and Omni-Express arrays with 200 ng (blood) or 400 ng (saliva) of DNA to
genotype 639,053 SNPs for the same 393 individuals at the Max Planck Institute. We called
genotypes using Illumina's GenomeStudio software and used PLINK [Purcell, et al. 2007] to
perform quality control analyses, removing individuals with > 2% missing data and SNPs
with less than a 99% call rate or MAF<5%. We also identified and removed related
individuals by using PLINK to estimate the proportion of identity by descent (IBD) for each
pair of individuals [Purcell, et al. 2007]. Among pairs of individuals with IBD proportion >
0.1 (indicating cousins or a closer relation), we removed the individual in each pair with the
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higher rate of missing genotype data. After quality control, 589,375 autosomal SNPs,
469,142 autosomal CpG sites, and 393 individuals were eligible for further analyses.
Principal Component Analysis
Principal component analysis of genome-wide SNP data—Prior to principal
component analysis, we used PLINK [Purcell, et al. 2007] to prune the data in windows of
50 bp (base pairs), removing one SNP from each pair of SNPs with r2>0.05. 54,616 SNPs
remained after pruning. We next standardized the allele counts as suggested in [Patterson, et
al. 2006], such that if C is a matrix of allele counts, with each row representing an
individual, the matrix of standardized allele counts is:
where
We then calculated the PCs of M. To adjust for population stratification, we considered two
sets of PCs: the set that were significant according to a Tracey-Widom test [Patterson, et al.
2006] (PCGWAS_TW) and the top ten PCs of M (PCGWAS).
Principal component analysis of genome-wide DNA methylation data—When
adjusting for population stratification in GWAS, it is common to work with a roughly
independent set of SNPs that have been pruned to remove highly correlated SNPs, as
described above. We took a similar approach for the methylation data, although to account
for differences in the correlation structure of methylation data compared to SNP data, we
performed more extensive correlation-based pruning than typically used for SNPs
(Supplementary Methods). As potential corrections for population stratification, we
considered the top ten PCs based on: the complete unpruned data (PCunpruned), data pruned
to keep only CpG sites with r2 < 0.25 (PCr2<0.25), or data pruned to keep only CpG sites
with r2 < 0.1 (PCr2<0.1).
In addition to the correlation-based pruning, we also devised a method of location-based
pruning to take advantage of information on the proximity of SNP variants to the
methylation probes by incorporating data on genetic variation from the 1000 Genomes
Project [1000 Genomes Project Consortium 2010]. For each CpG site we identified the
closest genetic variant with MAF>.01 in the 1000 Genomes Project, based on all samples in
the updated Phase I release. We then created seven pruned datasets that included only CpG
sites within a certain distance (0, 1, 2, 5, 10, 50, or 100 bp) of a genetic variant (lists of CpG
sites available at http://genetics.emory.edu/conneely). The purpose of this location-based
pruning was to focus on CpG sites that may proxy for SNP genotypes in situations where
SNP data may not be available. We hypothesized that the PCs from these CpG sites could
pick up on population differences in allele frequency of the genetic variants and thus may
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provide an appropriate adjustment for population stratification when genome-wide SNP data
are not available. Thus, we tested an additional seven sets of the top ten PCs based on CpG
sites located: directly on a genetic variant (PC0bp), within one (PC1bp), two (PC2bp), five
(PC5bp), ten (PC10bp), fifty (PC50bp), or one hundred base pairs (PC100bp) of a genetic
variant.
Assessing the Potential for Population Stratification in Methylation Data
To assess the potential for population stratification in our methylation data, we tested for
associations between methylation and self-reported race in all individuals who self-reported
as African-American (N=365) or Caucasian (N=23) in our data. We used the R package
CpGassoc [Barfield, et al. 2012] to perform a genome-wide methylation association study to
identify CpG sites that associated significantly with race. Analyzing each CpG site
separately, we performed a multivariate linear regression that modeled either the β-values or
M-values (the logit-transformed β-values log(β/(1- β)) described by [Du, et al. 2010]) on an
indicator for self-reported race (African-American vs. Caucasian) and included covariates
for sex, age, chip, and row on chip to adjust for age- and sex-dependent methylation along
with potential technical effects of chip and location on chip. To assess significance while
accounting for multiple testing we used the Benjamini-Hochberg FDR procedure and the
Holm method (a step down Bonferroni procedure) [Benjamini and Hochberg 1995; Holm
1979].
We next assessed the effectiveness of each set of PCs described above as proxies for self-
reported race in our data, since the goal of PC-based adjustment for population stratification
is to construct covariates that proxy for ancestry. For each set of PCs, we re-ran our
CpGassoc analysis including the top PCs (generally the top ten PCs, except with
PCGWAS_TW) as covariates in the model. When working with M-values, we computed
principal components based on M-values instead of the untransformed β-values. To assess
the potential of each set of PCs as proxies for ancestry, we considered the number of CpG
sites significantly associated with race before and after adjustment. For comparison, we also
applied the method of genomic control (GC) to adjust the test statistics by an estimated
inflation factor statistics [Bacanu, et al. 2000; Devlin and Roeder 1999; Devlin, et al.
2001a]. To estimate the GC inflation factor, we first computed tmed, the median t-statistic
from the unadjusted model. Since the squared t-statistics are approximately distributed as
λχ21 [Devlin, et al. 2001b], where λ represents an unknown inflation factor, we computed
the GC inflation factor as λGC = t2med /.4549, where .4549 is the median of the χ21
distribution. We then divided each of the test statistics by  before calculating p-values.
Simulations
To assess rates of type I error and power for the proposed adjustments, we performed a
series of simulations. Because of the difficulty of simulating realistic genome-wide
methylation and SNP data, we based our simulations on the genome-wide genotypes and
epigenotypes of randomly drawn subsets of individuals from the data described above. In
each simulation, we randomly sampled 100 of the 365 African American individuals and
included all 23 Caucasian individuals; this strategy was used because of the scarcity of
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Caucasian individuals in our data. For each sample of 123 individuals, we then simulated
either a continuous or dichotomous variable that had a different mean for Caucasians and
African Americans.
To estimate type I error rates for the continuous case, we simulated a variable Yi so that:
where α is a constant term, εi ~ N(0,1), and I(Caucasian) is an indicator variable that is 1 for
Caucasian and 0 for African-American individuals. We performed two sets of 5,000
simulations each: one where γ=0 (no population stratification) and one where γ>0
(population stratification is present). To test the ability of each method to control
experiment-wide type I error at the appropriate level (0.05), we used CpGassoc to perform a
genome-wide analysis for association between methylation and the simulated continuous
variable in each simulated dataset. CpGassoc fits a linear model for each CpG site that
models either the β- or M-value as a linear function of covariates. Our covariates included
the simulated continuous variable as well as age, sex, chip, and location on chip. In each
simulation, we next attempted to adjust for population stratification using each of the
methods described above, as well as GC [Bacanu, et al. 2000; Devlin and Roeder 1999;
Devlin, et al. 2001a] and Leek and Storey's surrogate variable analysis (SVA) method [Leek,
et al. 2012; Leek and Storey 2007; Leek and Storey 2008]. To avoid excessive
computational burden, each set of PCs was computed for the entire sample of individuals in
the simulation study (N=388) prior to performing simulations, rather than computing a
separate set for each simulation. To perform SVA we used the SVA R package to estimate
the surrogate variables via iteratively re-weighted surrogate variable analysis [Buja A 1992;
Leek and Storey 2007; Leek and Storey 2008] and to select the number of surrogate
variables to include in the analysis via permutation testing [Buja A 1992]. As with the PCs,
we then included the surrogate variables as additional covariates in the model. SVA
typically failed for a small number of simulations; for T1E simulations we assumed for the
sake of comparison that those unsuccessful runs would not have returned false positives,
while for power simulations we simply computed power based on the successful
simulations. The resulting estimate of type I error in each set of simulations was the
proportion of simulations with one or more Holm-significant CpG sites.
To estimate power, we simulated the continuous variable such that its mean depended on
both race and the methylation of a specific CpG site. The variable was simulated according
to a linear model where:
where α is a constant term, δ>0 is a constant slope term, εi ~ N(0,1), and βi represents the β-
value or M-value at the chosen CpG site. Here we performed two sets of 1,000 simulations
each: one where γ=0 (no population stratification) and one where γ>0 (population
stratification is present). We then used CpGassoc to test each CpG site for association as
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described above. Estimated power for each set of simulations was then the proportion of
simulations that correctly identified the chosen CpG site as Bonferroni-significant.
For the binary case, we performed similar simulations using a logit model. For each
individual, we simulated the probability of disease pi such that:
and simulated disease status as a Bernoulli(pi) random variable. To estimate type I error
rates, we created 5,000 simulated datasets where disease status was simulated with δ=0 and
either γ=0 (population stratification present) or γ>0 (population stratification present). We
then used CpGassoc to test each CpG site for association by fitting linear regressions that
modeled β-values as a linear function of disease status as well as age, sex, chip, and location
on chip, and tried adjusting for population stratification via all of the methods described
above. As above, we estimated type I error in each set of simulations as the proportion of
simulations with one or more Holm-significant CpG sites. To estimate power, we performed
1,000 simulations where δ>0, and proceeded in the same way as above.
Replication of previously published results—To compare the above methods in a
real-world setting we attempted to replicate two sets of previously published results: the top
eight CpG sites from a study of methylation and age [Teschendorff, et al. 2010] and a CpG
site that has shown strong association with smoking in several studies [Breitling, et al. 2012;
Breitling, et al. 2011; Shenker, et al. 2013; Sun, et al. 2013; Wan, et al. 2012].
We first analyzed eight CpG sites that we selected by taking the five CpG sites most
significantly associated with age in each of Supplementary Tables 3 and 5 in [Teschendorff,
et al. 2010]. For these analyses, we used our original data plus five additional individuals
who were not included in the simulations because they did not self-report as African-
American or Caucasian (four reported as mixed race and one as “other”), raising our sample
size to 393. We then recalculated all the PCs. We used CpGassoc to model β-values as a
linear function of age, with covariates for sex, chip, and location on chip. We then refit the
model including one of the sets of PCs described above as additional covariates, or used
genomic control or SVA [Leek, et al. 2012; Leek and Storey 2007]. As a gold standard, we
also ran the model including self-reported race for comparison (coded as categorical based
on self-reported race).
We next analyzed CpG site cg19859270, which has demonstrated strong association with
smoking across several studies [Breitling, et al. 2012; Breitling, et al. 2011; Shenker, et al.
2013; Sun, et al. 2013; Wan, et al. 2012], including a previous analysis in a subset of our
data (239 African American subjects with useable smoking data) as a replication sample in
Sun et al. [Sun, et al. 2013]. Here we modeled β-values as a function of the total current
KMSK (Kreek-McHugh-Schluger-Kellogg) score with the usual covariates for age, sex,
chip, and location (row) on chip. We then refit the model several times including each set of
PCs as covariates. Our analysis included 255 individuals for whom KMSK was available,
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including 239 self-identifying as African American, 13 as Caucasian, 2 as mixed, and 1 as
“other”.
For these analyses and others, we also performed secondary analyses adjusting for estimated
cell type proportions. We estimated the proportions of 6 cell types (monocytes,
granulocytes, CD8+ T-cells, CD4+ T-cells, NK cells, and B cells) for each individual from
their genome-wide methylation signatures, using the method of [Houseman, et al. 2012] to
infer proportions based on an external reference sample of cell-specific methylation profiles
[Reinius, et al. 2012]. We then performed secondary analyses where we included these
estimated cell type proportions as additional covariates in our replication studies of age and
smoking. For all regressions we standardized the cell type proportions to sum to exactly 1
for each individual, and then included 5 of the 6 proportions as covariates in our regression.
We also used these estimated proportions to investigate the ability of the top ten
methylation-based PCs to pick up on cell type heterogeneity (Supplementary Table 2).
Results
Our dataset included 365 African American and 23 Caucasian individuals, according to self-
report. The mean age was 41.5 (range 18-77), with 279 females and 109 males. For the
preliminary tests of genome-wide association between methylation β- or M-values and self-
reported race, we analyzed 469,142 autosomal CpG sites. 912 sites were associated with
race according to the conservative Holm method of adjustment for multiple testing, and
12,827 sites were associated at FDR<.05 (first row of Table I), suggesting that population
stratification is a potential confounder in DNA methylation studies as well as in GWAS.
We next performed similar analyses that included each set of PCs as additional covariates to
adjust for population stratification, and observed a substantial reduction in the number of
sites that significantly associated with race (Table I). Although 90 sites remained associated
with race after GC adjustment, inclusion of PCs from GWAS or methylation data generally
resulted in 0 or 1 Holm-significant sites. PCS based on genome-wide SNP data (PCGWAS
and PCGWAS_TW) were the most successful at removing inflation (λGC =1) but several sites
remained significantly associated with race after these corrections. In contrast, slight
genomic inflation remained after adjustment via methylation-based PCs
(1.02<λGC<1.18).but fewer FDR-significant sites remained. When we performed the
analysis using M-values instead of β-values (Supplementary Table I), we observed a similar
pattern except that the GWAS-based PCs appeared to fully correct for population
stratification, and the methylation-based PCs (now computed based on M-values) performed
somewhat worse in terms of genomic inflation and numbers of FDR-significant sites.
Table I suggests that both GWAS- and methylation-based PCs successfully proxied for self-
reported race, including sets based only on DNA methylation data. It is well-established that
population structure can generally be represented with the top PCs from GWAS data, but no
such pattern has been established for DNA methylation data. In our data, we observe that in
contrast to GWAS-based PCs (Figure 1A), the first methylation-based PC generally does not
represent variation due to population structure, suggesting that variation in methylation data
may be less influenced by population structure and more influenced by other factors. This is
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unsurprising considering that DNA methylation may be influenced by technical factors,
individual age, or cell type composition of individual samples. For example, when
examining the first ten components from most sets of methylation-based PCs, we found top
principal components to be significantly associated not only with race, but with age, chip,
row on chip, and cell type proportions estimated via the method of Houseman et al. [2012]
(Supplementary Table II). Figure 1 shows that in our data self-reported race associates with
the first PC of PCGWAS (Figure 1A) but with the 2nd and 3rd PCs of PC0bp (Figure 1B) and
the 4th and 6th PCs of PC50bp (Figure 1C). The difference between Figures 1B and 1C is
consistent with the idea that principal components based only on CpG sites harboring a SNP
(PC0bp) may provide the best proxy for SNP-based principal components when genome-
wide SNP data are unavailable. Supplementary Table II demonstrates a similar pattern for
the other methylation-based PCs, in which race correlates with higher-order PCs when PCs
are computed for CpG sites within ≤10 bp of SNPs.
To estimate type I error rates for the different approaches, we performed 5,000 simulations
as described in Methods, and fit the model using each of the proposed adjustments. To
provide a “gold standard” for our comparisons, we also fit the model adjusting for self-
reported race as a covariate. Results are presented in the first two columns of Table II (β-
values modeled as a function of a continuous phenotype), Supplementary Table III (M-
values modeled as a function of a continuous phenotype) and Table III (β-values modeled as
a function of a dichotomous phenotype). Prior to correction, the type I error rate was inflated
in the presence of population stratification (first row of Tables II and III and Supplementary
Table III). For continuous phenotypes, all of the proposed adjustments achieved or came
close to the targeted type I error of 0.05 both in the presence and absence of population
stratification (Table II and Supplementary Table III). For simulations based on a
dichotomous phenotype this was true in the absence of population stratification, but in the
presence of population stratification we observed mild inflation of the type I error rate,
which ranged from .0534 to .0718 after PC-based corrections. For all analyses, the most
conservative control of type I error was typically obtained with genomic control, with one
exception (Supplementary Table III).
Results from the power simulations are presented in the third and fourth columns of Table
II, Supplementary Table III and Table III. The most powerful approaches in all cases were
those that added only one additional covariate to the model (PCGWAS_TW and inclusion of
race as a covariate, with power ranging from 0.883 - 0.963, though we note that power
cannot be directly compared across the different models presented in the three tables).
Compared to these single-covariate approaches, adjustments involving the inclusion of 10
principal components showed somewhat lower power that ranged from 0.832 - 0.894 when
no population stratification was present, and from 0.749 - 0.871 in the presence of
population stratification. Among the adjustments based on 10 PCs, the correlation-based
pruning approaches that led to the largest reduction in race-associated sites in Table I
(PCunpruned, PCr2<0.25 and PCr2<0.1) were among the most powerful methylation-based
approaches when population stratification was present, but some of the location-based
pruning approaches performed as well or better. Interestingly, PCs based on CpG sites
within ≤10bp of SNPs were among the less powerful approaches, which is surprising given
the associations with race demonstrated by these sets of PCs (Supplementary Table II). We
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generally observed slightly lower power for surrogate variable analysis than for the PC-
based methods. Finally, the genomic control method performed well when there was no
population stratification, but in the presence of stratification it performed the worst of all
methods considered for continuous traits, with 0.662 power to detect an association in Table
II and power of .656 in Supplementary Table III.
We next attempted to replicate the top eight methylation-age associations reported by
Teschendorff et al. [Teschendorff, et al. 2010]. Figure 2 shows that for all eight CpG sites,
we successfully replicated the association with age in our data. Interestingly, correction with
PCs based on larger sets of CpG sites (PCr2<0.25, PCr2<0.1, PCunpruned, PC50bp, PC100bp) led
to the least significant results in the replicated age-association results (Figure 2). This may
be due to the greater association of these principal components with age (Supplementary
Table II). While genotype data is static, DNA methylation is dynamic and it is thus likely
that its principal components may vary with dynamic traits like age, as demonstrated in
Supplementary Table II. In contrast, adjustment via principal components based on genetic
variants (PCGWAS, PCGWAS_TW) or proxies for genetic variants within ≤10bp (PC0bp, ...,
PC10bp) led to stronger age-methylation associations, which makes sense given that genetic
variation is independent of age and those sets of PCs are less associated with age than the
other sets of methylation-based PCs (Supplementary Table II). SVA also led to stronger
associations, which makes sense given its goal to account for unmeasured factors that are
independent of the variable of interest [Leek, et al. 2012; Leek and Storey 2007]. Finally,
genomic control appeared to perform poorly in this context, likely because the large
inflation factor (λGC=3.07) was in part due to a widespread genomic pattern of association
between age and methylation. Notably, the inflation factor remained large even after
correcting for population stratification with GWAS-based principal components (λGC=3.13),
suggesting that the observed inflation was indeed due to factors other than population
stratification, and that genomic control may not be an appropriate correction in this case.
Because cell type heterogeneity is a potential confounder between methylation and age, we
refit the above models including covariates for estimated cell type proportions, as described
in Methods. Supplementary Figure 1 compares the –log10 p-values for cell-type-corrected
analyses vs. unadjusted analyses, and Supplementary Figure 2 summarizes the associations
with age after cell type adjustment. Notably, for all eight CpG sites the associations with age
become more significant upon adjustment for cell type for the models not adjusted for
population stratification (“no correction”) or those adjusted via GWAS or inclusion of race
as a covariate. For the models adjusted for population stratification with methylation-based
PCs, the pattern is less consistent, and it is important to note that here we have introduced a
large amount of collinearity to the model through the inclusion of both estimated cell type
proportions and the top ten methylation PCs. Supplementary Table II demonstrates
extremely high correlation between estimated cell type proportions and the top methylation-
based PCs; thus, by including the top 10 PCs in the model we are already adjusting for cell
type to some extent. In Supplementary Figure 1, adjustment for population stratification via
SVA or PCs based on CpG sites within ≤10 bp of a SNP typically yields cell-type-
unadjusted p-values that are similar to the cell-type-adjusted p-values for the “no correction”
or GWAS-based approaches, suggesting that these approaches may do the best job of
accounting for cellular heterogeneity as well as population stratification.
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We next attempted to replicate a previously reported association between methylation and
smoking [Breitling, et al. 2012; Breitling, et al. 2011; Shenker, et al. 2013; Sun, et al. 2013;
Wan, et al. 2012]. This result has already been replicated in the African-Americans in our
dataset with available smoking data (N = 239; [Sun, et al. 2013]), but as a proof-of-principle
we re-performed the analysis including individuals self-reporting as Caucasian, mixed race,
and other (N = 255). Comparing to the replication results from Sun et al. [Sun, et al. 2013]
(Figure 3, dotted line), we observe stronger associations between smoking and cg19859270
regardless of which method is used to adjust for population stratification. This may result
partially from the slight increase in sample size, but notably there was not much increase in
significance when no correction for population stratification was performed (leftmost point
on Figure 3). Upon adjustment for cell type proportions, results were similar for the methods
based on GWAS PCs, inclusion of race as a covariate, or no correction, but less significant
when methylation-based PCs were included; as above, this is consistent with high
collinearity between estimated cell type proportions and methylation-based PCs.
In contrast to the age replication, in the methylation-smoking analysis all of the methylation-
based PC methods led to more significant associations than the GWAS-based PC methods
(Figure 3). Adjustment for population stratification via PCr2<0.1 led to the most significant
association between cg19859270 and smoking (p=5.3×10−14), followed by the PC methods
using correlation-based pruning. The difference between Figures 2 and 3 is consistent with
the idea that unlike GWAS-based principal components, the top ten methylation-based
principal components pick up some age-associated methylation (10−26 < p < 10−7,
Supplementary Table II), and their inclusion as covariates can thus reduce power to detect
association with age. Sets of principal components that are based on CpG sites close to
SNPs may be better proxies for genetic variation and thus somewhat less associated with age
(as demonstrated in Supplementary Table II), and methods such as SVA will avoid this issue
entirely; this is consistent with the pattern shown in Figure 2. In contrast, because only a few
CpG sites associate with smoking, the principal components do not proxy for association
between methylation and smoking (p>.005 for all PCs tested); in this case all of the
methylation-based principal-component based methods perform similarly well, as in Figure
3. Similarly, adjustment via genomic control led to somewhat reduced significance in the
smoking analysis (Figure 3), but not the large reduction observed in the age analysis (Figure
2); this is likely because thousands of CpG sites across the genome have been shown to
associate with age [Alisch, et al. 2012; Christensen, et al. 2009; Numata, et al. 2012;
Rakyan, et al. 2010; Teschendorff, et al. 2010], while only a handful have been associated
with smoking [Breitling, et al. 2012; Breitling, et al. 2011; Shenker, et al. 2013; Sun, et al.
2013; Wan, et al. 2012].
Discussion
Our study is the first to address population stratification in studies of DNA methylation and
to propose and compare approaches to correct for population stratification. When adjusting
for population stratification, an important distinction between classic GWAS and genome-
wide studies of DNA methylation is that the top principal components of methylation data
generally proxy for many factors beyond ancestry, including technical artifacts such as batch
effects, cell type heterogeneity, and sample age. Thus, adjustment with methylation-based
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PCs typically requires the inclusion of a greater number of PCs and may potentially lead to
power loss if the principal components from DNA methylation proxy for the variables of
interest, as exemplified in the replication of methylation-age associations in Figure 2.
However, sample age is a confounder rather than a variable of interest in most studies, as are
cellular heterogeneity and technical factors. Thus, the ability of principal components
approaches and SVA to proxy for these factors in addition to ancestry can generally be
considered an advantage of such methods. Cellular composition is in a sense an analogous
problem to population stratification: just as individual genetic background reflects a mixture
of different ancestries, individual blood samples reflect a mixture of different cell types. The
association of both race and estimated cell type proportions with top methylation PCs
(Supplementary Table II) does suggest that methylation-based approaches could adjust for
both of these factors at once. Our analyses in Supplementary Figures 1-3 suggested that
methylation-based PC and SVA approaches do adjust for cellular heterogeneity to some
extent, and that including both the estimated cell type proportions and the top ten principal
components in the same model may lead to collinearity and reduced power. However, our
study was designed to focus on population stratification, and our results do not provide
sufficient evidence to assess whether these methods will fully control for other confounding
factors such as cellular heterogeneity; further work will be needed to address this interesting
problem.
Our proposed approach to compute the principal components of sets of CpG sites near SNPs
can help narrow the focus to variation in methylation that reflects genetic variation and
compute PCs that are better proxies for ancestry. Restricting to CpG sites within 0-50 bp of
genetic variants will enrich for CpG sites that may proxy for genetic variation due to the
possibility of a SNP influencing probe binding specificity, rather than those that proxy for
genetic variation due to the influence of mQTLs. Given inter-tissue differences in
methylation patterns [e.g. Byun, et al. 2009], and emerging evidence that mQTLs and
eQTLs are in part tissue-specific [Nica, et al. 2011; Smith et al. 2013], computation of
principal components based on sets of CpG sites within 50 bp of SNPs may provide an
adjustment strategy that is robust regardless of what tissue type is studied. Another
advantage of this approach is its computational simplicity compared to pruning based on
correlation. To facilitate the use of this approach by other groups, we have made available
our lists of CpG sites from the Illumina 450K that are located within 0-100bp of 1000
Genomes Project variants with minor allele frequency>.01, along with R code to compute
the principal components (http://genetics.emory.edu/conneely). Variations of this approach
such as focusing on CpG sites near ancestry informative markers could also be useful,
although this approach would require knowledge about the underlying populations
potentially driving stratification as well as pre-identified set of thousands of ancestry-
informative markers.
In conclusion, we have proposed and made available a simple approach to adjust for
population stratification in studies of DNA methylation that does not require the collection
of SNP genotype data. Potential limitations of our study included the focus on two self-
reported race categories and the small number of Caucasians in our data, and future studies
should seek to generalize our results in larger samples from other populations. However,
even with this limited dataset we have demonstrated the potential of population stratification
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to inflate type I error rates in DNA methylation association studies. Our simulations show
that our approach appropriately effectively removes this inflation while remaining nearly as
powerful as using the top principal components from genome-wide SNP data, thus providing
an effective way to adjust for population stratification in DNA methylation studies when
genome-wide SNP data are unavailable.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Principal components by self-reported race
A) 1st and 2nd PC from PCGWAS B) 2nd and 3rd PC from PC0bp C) 4th and 6th PC from
PC50bp. Red points = African American individuals; blue points = Caucasian individuals.
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Figure 2. Replication of aging results
Replication of the top eight CpG sites associated with aging [Teschendorff, et al. 2010],
using 16 different approaches to adjust for population stratification.
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Figure 3. Replication of smoking results
Replication of the top CpG site associated with smoking in [Breitling, et al. 2012; Breitling,
et al. 2011; Shenker, et al. 2013; Sun, et al. 2013; Wan, et al. 2012], using 16 different
approaches to adjust for population stratification. The dotted line indicates the p-value from
a previous replication based on 239 African Americans from our sample [Sun, et al. 2013].
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Table I
Total number of sites associated with race, before and after correction for population stratification
Correction method used # markers used to compute PCs # FDR-significant CpG sites # Holm-significant CpG sites λ GC
No correction - 12827 912 2.09
GC - 578 90 1
PCgwas 54,610 13 3 1
PCGWAS TW 54,610 19 4 1
PCunpruned 469,142 1 1 1.08
PCr2<0.25 225,440 0 0 1.06
PCr2<0.1 121,855 0 0 1.11
PC0bp 7,326 0 0 1.16
PC1bp 17,105 1 1 1.18
PC2bp 20,336 1 1 1.18
PC5bp 31,178 1 1 1.12
PC10bp 48,998 1 1 1.10
PC50bp 174,510 1 1 1.02
PC100bp 271,877 1 1 1.05
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Table II
Type I error rate and power for analysis of a continuous trait, by method of correction for population
stratification
Rate of type I error Power
Correction method No population stratification Stratification present No population Stratification stratification present
No correction 0.0364 0.2690 0.964 ---
Race included as covariate 0.0344 0.0344 0.963 0.963
GC 0.0116 0 0.908 0.662
PCgwas 0.0348 0.0326 0.879 0.871
PCGWAS_TW 0.0340 0.0322 0.962 0.951
PCunpruned 0.0466 0.0478 0.885 0.860
PCr2<0.25 0.0464 0.0514 0.888 0.861
PCr2<0.1 0.0448 0.0500 0.893 0.857
PC0bp 0.0418 0.0412 0.832 0.828
PC1bp 0.0380 0.0374 0.880 0.858
PC2bp 0.0390 0.0376 0.887 0.852
PC5bp 0.0382 0.0436 0.888 0.856
PC10bp 0.0404 0.0430 0.893 0.860
PC50bp 0.0496 0.0462 0.894 0.869
PC100bp 0.0464 0.0450 0.884 0.860
SVA 0.0460 0.0506 0.881 0.839
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Table III
Type I error rate and power for analysis of a dichotomous trait, by method of correction for population
stratification
Rate of type I error Power
Correction method No population stratification Stratification present No population stratification Stratification present
No correction 0.0304 0.1354 0.948 ---
Race included as covariate 0.0290 0.0692 0.945 0.885
GC 0.0084 0.0488 0.903 0.801
PCgwas 0.0304 0.0534 0.869 0.794
PCGWAS_TW 0.0290 0.0712 0.946 0.883
PCunpruned 0.0402 0.0694 0.880 0.802
PCr2<0.25 0.0370 0.0704 0.885 0.807
PCr2<0.1 0.0356 0.0676 0.885 0.800
PC0bp 0.0398 0.0650 0.840 0.749
PC1bp 0.0392 0.0678 0.871 0.789
PC2bp 0.0398 0.0708 0.874 0.792
PC5bp 0.0410 0.0708 0.875 0.795
PC10bp 0.0392 0.0718 0.880 0.797
PC50bp 0.0390 0.0700 0.884 0.804
PC100bp 0.0382 0.0718 0.883 0.806
SVA 0.0358 0.0794 0.790 0.689
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